HomeNTRA • NASDAQ
add
Natera Inc
Nakaraang pagsara
$196.11
Sakop ng araw
$198.28 - $209.28
Sakop ng taon
$131.81 - $256.27
Market cap
29.54B USD
Average na Volume
1.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 665.50M | 39.79% |
Gastos sa pagpapatakbo | 468.21M | 28.50% |
Net na kita | 47.26M | 187.89% |
Net profit margin | 7.10 | 162.89% |
Kita sa bawat share | 0.36 | 187.80% |
EBITDA | -13.69M | 77.35% |
Aktuwal na % ng binabayarang buwis | 454.63% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.08B | 11.14% |
Kabuuang asset | 2.40B | 44.41% |
Kabuuang sagutin | 685.93M | 47.41% |
Kabuuang equity | 1.71B | — |
Natitirang share | 141.73M | — |
Presyo para makapag-book | 16.00 | — |
Return on assets | -2.70% | — |
Return on capital | -3.37% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 47.26M | 187.89% |
Cash mula sa mga operasyon | 73.89M | 39.71% |
Cash mula sa pag-invest | -71.59M | -543.93% |
Cash mula sa financing | 32.41M | 195.30% |
Net change in cash | 34.70M | -34.21% |
Malayang cash flow | 16.99M | -69.31% |
Tungkol
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Itinatag
Ene 1, 2004
Headquarters
Website
Mga Empleyado
6,138
